Sotio profits from access to biotech professionals
Country of origin
Sotio is dedicated to connecting patients and science
Sotio has been building a diverse biotechnology portfolio through its own R&D, collaborations and investments since 2010. It is focuses on immuno-oncology and developing innovative methods of the treatment of cancer. The Basel-Stadt-based company is conducting multiple Phase I to III clinical trials and projects in preclinical stage.
”We evaluated several European business locations – in the end, Basel stood out as the most convenient location for Sotio. The region has a large talent pool, which is an important criterion for us. We plan to add top biotechnology professionals to our global team. The business environment is very friendly. The international community and the proximity to Germany and France are a big plus.Pavel SolskýCFO and CCO Sotio
Basel Area Business & Innovation helped us a lot during the settlement process: They did a good job in setting up meetings with the right people. The process from the first contact to our registration was smooth.